Cargando…
A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer
BACKGROUND: Transrectal ultrasound (TRUS) guided biopsy for prostate cancer is prone to random and systemic error and has been shown to have a negative predictive value of 70%. PRECISION and PRECISE are among the first randomised studies to evaluate the new MRI-targeted biopsy (MRI-TB) pathway with...
Autores principales: | Kasivisvanathan, Veeru, Chan, Vinson Wai-Shun, Clement, Keiran D., Levis, Brooke, Haider, Masoom, Agarwal, Ridhi, Emberton, Mark, Pond, Gregory R., Takwoingi, Yemisi, Klotz, Laurence, Moore, Caroline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812968/ https://www.ncbi.nlm.nih.gov/pubmed/35113918 http://dx.doi.org/10.1371/journal.pone.0263345 |
Ejemplares similares
-
A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol
por: Kasivisvanathan, Veeru, et al.
Publicado: (2017) -
There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022) -
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
por: Asif, Aqua, et al.
Publicado: (2023) -
Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy
por: Uriburu-Pizarro, Facundo, et al.
Publicado: (2017) -
Transperineal vs. transrectal biopsy in MRI targeting
por: Grummet, Jeremy, et al.
Publicado: (2017)